Inflammatory pattern in hemodiafiltration

Contributions to Nephrology

Volumn 161, Issue , 2008, Pages 185-190

  Panichi, V ^a,b   Paoletti, S ^a   Consani, C ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Dipartimento Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE;

BLOOD; HEMODIAFILTRATION; HUMAN; INFLAMMATION; REVIEW;

C-REACTIVE PROTEIN; CYTOKINES; HEMODIAFILTRATION; HUMANS; INFLAMMATION;

EID: 48049120898     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000130676     Document Type: Conference Paper

References (17)

1. Reiss AB, Glass AD: Atherosclerosis: immune and inflammatory aspects. J Invest Med 2006;54:123-131.
2. Arici M, Walls J: End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001;59:407-414.
3. Roberts MA, Hare DL, Ratnaike S, Ierino FL: Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease. Am J Kidney Dis 2006;48:341-360.
4. Kaysen GA: The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001;12:1549-1557.
5. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin A: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-114.
6. Stenvinkel P, Heinburger O, Paultre F, et al: Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
7. Panichi V, De Pietro S, Andreini B, Migliori M, Tessore V, Taccola D, Rindi P, Palla R, Tetta C: Cytokine production in haemodiafiltration: a multicentre study. Nephrol Dial Transplant 1998;13:1737-1744.
8. Schouten WEM, Grooteman MPC, van Houte AJ, et al: Effects of dialysers and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant 2000;15:379-384.
9. Kerr PG, Sutherland WH, de Jong S, Vaithalingham I, Williams SM, Walker RJ: The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis: membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial. Am J Kidney Dis 2007;49:533-539.
10. Ollson J, Dadfar E, Paulsson J, Laundahl J, Moshfegh A, Jacobson SH: Preserved leukocyte CD1b expression at the site of interstitial inflammation in patients with high-flux hemodiafiltration. Kidney Int 2007;71:582-588.
11. Carracedo J, Merino A, Nogueras S, Carretero D, Berdud I, Ramirez R, Tetta C, Rodriguez M, Martin-Malo A, Aljama P: On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: a prospective, crossover study. J Am Soc Nephrol 2006;17:2315-2321.
12. Ramirez R, Carracedo J, Merino A, Nogueras S, Alvarez-Lara MA, Rodriguez M, Martin-Malo A, Tetta C, Aljama P: Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. Kidney Int 2007;72:109-113.
13. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG: Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003;14:415-424.
14. Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, et al: Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004;19:108-120.
15. Shiffl H: Prospective randomized cross-over long-term comparison of online hemodiafiltration and ultrapure high-flux hemodialysis. Eur J Med Res 2007;12:26-33.
16. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006;69:2087-2093.
17. Panichi V, Manca-Rizza G, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R: Chronic inflammation and mortality in hemodialysis: effects of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 2008 (in press).